Investors Asset Management of Georgia’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $993K | Buy |
17,235
+351
| +2% | +$20.2K | 0.35% | 79 |
|
|
2026
Q1 | $1.02M | Buy |
16,884
+6,650
| +65% | +$388K | 0.42% | 70 |
|
|
2025
Q4 | $552K | Sell |
10,234
-65
| -0.6% | -$3.13K | 0.23% | 100 |
|
|
2025
Q3 | $464K | Buy |
10,299
+701
| +7% | +$32.7K | 0.2% | 106 |
|
|
2025
Q2 | $444K | Buy |
9,598
+1,190
| +14% | +$58.4K | 0.21% | 102 |
|
|
2025
Q1 | $513K | Sell |
8,408
-149
| -2% | -$8.69K | 0.26% | 89 |
|
|
2024
Q4 | $484K | Buy |
8,557
+785
| +10% | +$43.9K | 0.24% | 91 |
|
|
2024
Q3 | $402K | Sell |
7,772
-300
| -4% | -$14.1K | 0.19% | 102 |
|
|
2024
Q2 | $335K | Buy |
8,072
+326
| +4% | +$14.6K | 0.16% | 116 |
|
|
2024
Q1 | $420K | Buy |
7,746
+1,445
| +23% | +$73.6K | 0.2% | 102 |
|
|
2023
Q4 | $323K | Sell |
6,301
-168
| -3% | -$8.82K | 0.16% | 111 |
|
|
2023
Q3 | $370K | Sell |
6,469
-149
| -2% | -$9.13K | 0.2% | 108 |
|
|
2023
Q2 | $423K | Hold |
6,618
| – | – | 0.22% | 101 |
|
|
2023
Q1 | $459K | Hold |
6,618
| – | – | 0.24% | 96 |
|
|
2022
Q4 | $476K | Sell |
6,618
-133
| -2% | -$10K | 0.25% | 97 |
|
|
2022
Q3 | $480K | Hold |
6,751
| – | – | 0.25% | 95 |
|
|
2022
Q2 | $520K | Hold |
6,751
| – | – | 0.27% | 86 |
|
|
2022
Q1 | $493K | Buy |
6,751
+100
| +2% | +$6.71K | 0.25% | 106 |
|
|
2021
Q4 | $415K | Hold |
6,651
| – | – | 0.2% | 113 |
|
|
2021
Q3 | $394K | Sell |
6,651
-100
| -1% | -$6.59K | 0.2% | 110 |
|
|
2021
Q2 | $451K | Hold |
6,751
| – | – | 0.24% | 97 |
|
|
2021
Q1 | $426K | Hold |
6,751
| – | – | 0.25% | 99 |
|
|
2020
Q4 | $419K | Sell |
6,751
-150
| -2% | -$9.22K | 0.28% | 84 |
|
|
2020
Q3 | $416K | Buy |
6,901
+375
| +6% | +$22.6K | 0.28% | 81 |
|
|
2020
Q2 | $384K | Sell |
6,526
-100
| -2% | -$5.98K | 0.27% | 85 |
|
|
2020
Q1 | $369K | Hold |
6,626
| – | – | 0.3% | 73 |
|
|
2019
Q4 | $425K | Buy |
6,626
+50
| +0.8% | +$2.86K | 0.26% | 90 |
|
|
2019
Q3 | $333K | Buy |
6,576
+185
| +3% | +$8.7K | 0.21% | 108 |
|
|
2019
Q2 | $290K | Buy |
6,391
+590
| +10% | +$27.5K | 0.2% | 114 |
|
|
2019
Q1 | $277K | Buy |
5,801
+125
| +2% | +$6.23K | 0.19% | 116 |
|
|
2018
Q4 | $295K | Sell |
5,676
-1,087
| -16% | -$58.4K | 0.24% | 105 |
|
|
2018
Q3 | $420K | Buy |
6,763
+50
| +0.7% | +$2.97K | 0.29% | 86 |
|
|
2018
Q2 | $371K | Buy |
6,713
+150
| +2% | +$8.1K | 0.27% | 97 |
|
|
2018
Q1 | $415K | Buy |
6,563
+115
| +2% | +$7.4K | 0.31% | 82 |
|
|
2017
Q4 | $395K | Sell |
6,448
-240
| -4% | -$15K | 0.28% | 90 |
|
|
2017
Q3 | $426K | Sell |
6,688
-300
| -4% | -$17.5K | 0.31% | 79 |
|
|
2017
Q2 | $389K | Buy |
6,988
+1,125
| +19% | +$61.2K | 0.27% | 88 |
|
|
2017
Q1 | $319K | Buy |
5,863
+1,385
| +31% | +$76K | 0.22% | 101 |
|
|
2016
Q4 | $262K | Buy |
+4,478
| New | +$245K | 0.19% | 110 |
|
|
2016
Q3 | – | Sell |
-3,283
| Closed | -$241K | – | 135 |
|
|
2016
Q2 | $241K | Buy |
3,283
+125
| +4% | +$8.83K | 0.19% | 112 |
|
|
2016
Q1 | $202K | Hold |
3,158
| – | – | 0.17% | 118 |
|
|
2015
Q4 | $217K | Buy |
+3,158
| New | +$209K | 0.18% | 111 |
|
|
2015
Q3 | – | Sell |
-3,185
| Closed | -$212K | – | 130 |
|
|
2015
Q2 | $212K | Hold |
3,185
| – | – | 0.18% | 118 |
|
|
2015
Q1 | $205K | Buy |
+3,185
| New | +$199K | 0.17% | 121 |
|
Other funds holding BMY
Investors Asset Management of Georgia's BMY Position: Q2 2026 in Review
Investors Asset Management of Georgia increased its Bristol-Myers Squibb (BMY) stake by 2.1% in Q2 2026, buying an estimated $20.2K and bringing the position to 17,235 shares worth $993K. The position accounts for 0.35% of the portfolio, ranked #79.
Investors Asset Management of Georgia first reported a position in BMY in Q1 2015 and has held it in 44 quarters since. The position peaked at $1.02M in Q1 2026. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Investors Asset Management of Georgia held 17,235 shares of Bristol-Myers Squibb worth $993K as of Q2 2026.
- Investors Asset Management of Georgia bought 351 Bristol-Myers Squibb shares in Q2 2026, an estimated $20.2K.
- Bristol-Myers Squibb made up 0.35% of Investors Asset Management of Georgia's portfolio in Q2 2026, its #79 holding.
- Investors Asset Management of Georgia first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 44 quarters since.
- Investors Asset Management of Georgia's Bristol-Myers Squibb position peaked at $1.02M in Q1 2026.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Investors Asset Management of Georgia's 13F filing for Q2 2026, filed 22 Jul 2026.